Michelle A. Hladunewich, MD, MS, FASN, BRCU Faculty

Michelle A. Hladunewich, MD, MS, FASN, received her Doctor of Medicine degree at the University of Alberta and completed her Internal Medicine training at the University of Toronto and her Critical Care and Nephrology fellowships at Stanford University Medical Center.
In addition to her research training in glomerular physiology, Dr. Hladunewich earned a Master of Science degree in Clinical Investigation at Stanford University. In 2003, she joined the University of Toronto as an Assistant Professor of Medicine and was promoted to Associate Professor in 2013.
Dr. Hladunewich is the Clinical Trials Director at the Toronto Glomerulonephritis Clinic and Registry and the co-chair of the recruitment committee for two large glomerulonephritis consortiums: Nephrotic Syndrome Study Network (NEPTUNE) and Cure Glomerulonephropathy (CureGN) Consortium. She is the medical lead for the Kidney Disease and Pregnancy Clinic (PreKid Clinic) and the Director of both the Division of Nephrology and the Division of Obstetric Medicine at Sunnybrook Health Sciences Centre in Toronto, Canada. Her research program includes studies in glomerular-based disease as well as pregnancy-related kidney disease. Dr. Hladunewich is currently the Ontario Renal Network Medical Lead for Glomerulonephritis and Specialty Clinics.